Leg Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Leg Pain Relief
Generic name: ZINC, COPPER, HYPERICUM PERFORATUM
Manufacturer: Laboratoires Boiron
Product type: HUMAN OTC DRUG
SPL set ID: 07f85300-bf90-11e7-81d0-424c58303031
SPL ID: 06ea67d8-b619-776b-e063-6294a90a3185
Version: 6
Effective date: 2023-10-04
Source export date: 2026-11-06
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/b0d9ca61dc485ebaf55e14a76d7d677668e40ef1e1978cdbcc4d73d58eba0b99/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:46:17

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Leg Pain Relief	openfda.brand_name
generic name		ZINC, COPPER, HYPERICUM PERFORATUM	openfda.generic_name
manufacturer name		Laboratoires Boiron	openfda.manufacturer_name
ndc	package	0220-9228-43	openfda.package_ndc
ndc	product	0220-9228	openfda.product_ndc
ndc11	package	00220922843	derived:openfda.package_ndc
spl id		06ea67d8-b619-776b-e063-6294a90a3185	id
spl set id		07f85300-bf90-11e7-81d0-424c58303031	set_id
unii		XK4IUX8MNB	openfda.unii
unii		789U1901C5	openfda.unii
unii		J41CSQ7QDS	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor before use in children under 2 years of age. Stop use and ask a doctor if symptoms persist for more than 7 days or worsen. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.